592 POSTER Obatoclax (GX17–070), a small molecule pan-bcl-2 inhibitor, in combination with docetaxel in a phase I/II trial enrolling patients with relapsed non-small cell lung cancer (NSCLC)

Autor:	Martin J. Edelman, Donald W. Northfelt, Charles Williams, J. Adams, D. A. Van Echo, Peter Rosen, M. S. Berger, Eric B. Haura, Shakun Malik, Alberto Chiappori
Rok vydání:	2008
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry non-small cell lung cancer (NSCLC) medicine.disease Small molecule Bcl-2 Inhibitor chemistry.chemical_compound Phase i ii Docetaxel chemistry Internal medicine Medicine business medicine.drug Obatoclax
Zdroj:	European Journal of Cancer Supplements. 6:185
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(08)72526-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1ac3b5b66f5055bfacf53fe10b71d974 https://doi.org/10.1016/s1359-6349(08)72526-6 Zobrazit plný text záznamu Full Text from ScienceDirect